Gibson Mara L, Hohmeier Kenneth C, Smith Cindy T
University of Tennessee Health Science Campus, College of Pharmacy, 193 Polk Avenue, Suite 2D, Nashville, TN 37210, USA.
Reeves-Sain, 1801 Memorial Blvd, Murfreesboro, TN 37129, USA.
Pharmacogenomics. 2017 Feb;18(3):227-233. doi: 10.2217/pgs-2016-0161. Epub 2017 Jan 23.
To determine patient knowledge, interest and willingness-to-pay for pharmacogenomics testing in a community pharmacy.
PATIENTS & METHODS: The link to a cross-sectional, anonymous online survey was distributed to a convenience sample of patients. The contingent valuation method was used to assess willingness-to-pay.
Twenty seven surveys were completed. Eighty one percent of patients were interested in the service, but patients felt that they would be more likely to use the service if insurance covered the cost.
Patients indicated interest in a pharmacogenomics test, but varying levels of willingness-to-pay. Patients may not be able to connect the benefits of testing to their health, justifying further patient education in order to increase the viability of pharmacogenomics testing as a pharmacy service.
确定社区药房中患者对于药物基因组学检测的知识、兴趣及支付意愿。
向便利抽样的患者分发了一项横断面匿名在线调查的链接。采用条件估值法评估支付意愿。
共完成27份调查问卷。81%的患者对该项服务感兴趣，但患者认为若保险能覆盖费用，他们更有可能使用该服务。
患者表明对药物基因组学检测感兴趣，但支付意愿程度各异。患者可能无法将检测的益处与自身健康联系起来，这表明需要进一步开展患者教育，以提高药物基因组学检测作为药房服务的可行性。
